Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Accumulated Depreciation & Amortization (2020 - 2022)

Terns Pharmaceuticals (TERN) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $1.4 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Accumulated Depreciation & Amortization rose 18.31% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Dec 2022, up 18.31%, and an annual FY2022 reading of $1.4 million, up 18.31% over the prior year.
  • Accumulated Depreciation & Amortization was $1.4 million for Q4 2022 at Terns Pharmaceuticals, up from $1.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.4 million in Q4 2022 and bottomed at $689000.0 in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 3 years is $1.1 million, with a median of $1.2 million recorded in 2021.
  • The sharpest move saw Accumulated Depreciation & Amortization soared 71.99% in 2021, then increased 18.31% in 2022.
  • Year by year, Accumulated Depreciation & Amortization stood at $689000.0 in 2020, then skyrocketed by 71.99% to $1.2 million in 2021, then grew by 18.31% to $1.4 million in 2022.
  • Business Quant data shows Accumulated Depreciation & Amortization for TERN at $1.4 million in Q4 2022, $1.2 million in Q4 2021, and $689000.0 in Q4 2020.